DailyIQ
Last updatedUpdating…

AHR·American Healthcare REIT Inc.

$50.48
+0.01 (+0.02%)
After Hours
High
$50.85
Open
$50.60
Market Cap
11.08B
52W High
$59.50
Low
$50.02
P. Close
$50.48
P/E
91.56
52W Low
$40.00
Fwd P/E
50.98
DailyIQ Est.
$66.72
Inst. Ownership
1.0%
Short Interest
11.33%
Days to Cover
9.3
Technical Score (1D)
14
BEARISH
News Sentiment
54
MIXED
On Oct 6, American Healthcare REIT (AHR) fell 7.8 % over the previous month, and technical analysis indicated the stock had entered oversold territory according to RSI analysis. On the same day, analysts reported that AHR could deliver earnings that exceed earlier forecasts, suggesting a potential turnaround. The company’s fundamentals and market positioning were cited as supporting a modest upside as selling pressure subsides. The article noted that Wall Street analysts largely agreed on the earnings outlook, implying that the stock may rebound. No other developments were reported for that date.
LOW TARGET
$55 +8.9%
2 analysts
MEAN TARGET
$64 +27.6%
7 analysts
HIGH TARGET
$74 +46.6%
12 analysts
PRICE RANGE
$55.00 - $74.00
SB / B / H / S / SS
7/11/1/1/1
DAILYIQ EST.
$66.72 (+32.1%)
Bought (1Y)
0 shares
$0
Sold (1Y)
120,891 shares
$6.7M
Foster Mark E.EVP, GC & Secretary
Sell1,500 shares2026-09-25
Foster Mark E.EVP, GC & Secretary
Sell2,000 shares2026-09-01
Prosky Danny-
Option Exercise20,912 shares2026-07-21
Prosky Danny-
Option Exercise30,886 shares2026-07-21
Prosky Danny-
Award/Grant2,594 shares2026-07-21
74/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Net Margin
3.3%
Return on Equity
2.1%

EPS

EstBeatMiss
$0.14$0.17$0.21$0.25$0.29Q3'25Q3'26
QtrEstActual+/−
Q3'26$0.16 - -
Q3'25$0.15$0.27+74.9%

Revenue

EstBeatMiss
$552M$597M$643M$689M$734MQ3'25Q3'26
QtrEstActual+/−
Q3'26$713M - -
Q3'25 - $573M -

Market Data

AHR Stock Snapshot

BEARISH14/100
$50.49+$0.01 (0.0%)
Market cap
11.08B
P/E ratio
91.6
Day range
$50.02 – $50.85
News sentiment
54/100 · Neutral
Analyst target
$64.40 (+27.6%)
Consensus
Buy · 21 analysts
52-week range+26.2% off low · -15.1% from high
$40.00$59.50
Price $50.49 DailyIQ Est. $66.72

The trend on AHR is bearish, and the indicator set is confirming it rather than diverging. The stock is liquid enough that positioning changes get absorbed without distorting the trend.

Behaviour On Record

What AHR's own history says about today's numbers

Realized volatility (21d)
13.0% 0th pct
vs 200-day average
-1.1%
Up days (1y)
52%

American Healthcare REIT Inc. is currently running 13.0% annualised volatility over the last 21 sessions. Measured against AHR's own 3 years of daily returns rather than a market-wide average, that is the 0th percentile — unusually subdued by its own history, against a typical reading of 31.0%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

Price sits -1.1% from its 200-day moving average. Against every other day in its history, that gap ranks at the 3rd percentile — a narrower gap than it typically runs. Over the past year AHR closed higher on 52% of sessions, and it is currently 1 session into a falling streak.

Overnight risk is measurable too: AHR has opened more than 2% away from the prior close in 91 of 666 sessions (13.7% of the time), with the largest gaps running +44.0% and -10.2%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

All figures computed from 667 daily closes between 2024-02-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against AHR's own 3-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of AHR's sector?

American Healthcare REIT Inc. sits in the Real Estate sector, currently ranked 11th of 12 GICS sectors by relative-strength rotation score (lagging).

Sector rank
#11 of 12
Sector state
Lagging
Sector rotation score
18

Options Market

What is the options market pricing for AHR?

CallsPuts

For American Healthcare REIT Inc.'s nearest expiry (2026-10-16, 10 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.55), with at-the-money implied volatility around 51.6%. The options market is pricing roughly a ±7.2% move by that expiry — a range of about $48.17–$55.63.

Put/call ratio (2026-10-16)
0.55
ATM implied volatility
51.6%
Total open interest
702
Expected move by 2026-10-16
±7.2% ($48.17–$55.63)

Analyst Rating Changes

Are analysts turning bullish or bearish on AHR?

Scotiabank most recently reiterated its rating on American Healthcare REIT Inc. to Sector Outperform on Sep 2, 2026 with a price target of $62 (from $56). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Scotiabank — Sector Outperform
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Sep 2, 2026ScotiabankMaintainedSector Outperform$56 → $62
Aug 31, 2026BarclaysMaintainedOverweight$61 → $66
Aug 19, 2026KeybancMaintainedOverweight$58 → $68
Aug 14, 2026Truist SecuritiesMaintainedBuy$57 → $61
Aug 14, 2026RBC CapitalMaintainedOutperform$56 → $61
Aug 13, 2026CitigroupMaintainedBuy$55 → $65
Jul 27, 2026CitizensMaintainedMarket Outperform$60 → $65
Jul 21, 2026Compass PointInitiatedBuy$70
Jul 8, 2026UBSMaintainedBuy$60 → $63
Jul 7, 2026BarclaysInitiatedOverweight$61
Jun 23, 2026CitigroupUpgradeNeutral → Buy$55
Jun 18, 2026ScotiabankMaintainedSector Outperform$59 → $51

News Sentiment Analysis

Sentiment gathered from recent headlines

54/100
Strong NegativeNeutralStrong Positive
MIXED

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
American Healthcare REIT (AHR) fell 7.8% over the previous month, but technical analysis indicates the stock is now oversold. Analysts largely agree that AHR could report earnings that exceed earlier forecasts, suggesting a potential rebound. The company’s fundamentals and market positioning support a modest upside as selling pressure subsides.
What did this article say?
American Healthcare REIT (AHR) achieved a Zacks Rank of #2 (Buy) in October 2022, placing it among the top performers in the Finance sector. Analysts noted a 5.6% increase in the consensus full‑year earnings estimate over the previous three months, indicating improving sentiment. The company’s position at #6 in the sector rank reflects its relative strength compared to 890 peers. The positive earnings outlook suggests potential upside for investors, though the impact is moderate and already partially priced.
What did this article say?
American Healthcare REIT (AHR) was highlighted as a favorable investment due to rising senior‑care housing demand and outpatient service expansion, which are expected to lift funds from operations (FFO) and net operating income (NOI). The analysis noted that these sector tailwinds support a sustainable dividend and provide long‑term upside potential. The article emphasized that AHR’s current valuation reflects these growth drivers, positioning the stock as a buy for investors seeking exposure to the healthcare real‑estate sector.
What did this article say?
American Healthcare REIT, Inc. (AHR) announced the schedule for its third quarter 2026 earnings release and accompanying conference call. The earnings report will be issued on November 5, 2026, after market close, with a public call and webcast on November 6, 2026. Executives will review results, discuss recent events, and answer investor questions during the call. The announcement provides investors with the timing of financial disclosures but does not indicate any change to guidance or performance expectations.
What did this article say?
American Healthcare REIT (AHR) is highlighted by Zacks Equity Research as a compelling play due to robust demand for modern healthcare properties, despite broader REIT headwinds such as higher interest rates and construction costs. The analysis notes that AHR’s portfolio is well-positioned with strong balance sheets and limited development pipeline, providing room for growth. While aging properties and tenant stress pose potential risks, the overall outlook remains positive, with AHR benefiting from a healthy demand environment across healthcare, industrial, and office markets.
What did this article say?
Zacks identifies American Healthcare REIT (AHR) as a compelling buy despite broader REIT sector headwinds from higher rates and construction costs. The firm notes AHR’s diversified portfolio across health care, industrial, lodging, office and infrastructure, which helps mitigate occupancy risks. AHR’s strong balance sheet and growth‑oriented pipeline position it to capitalize on demand for modern assets, potentially offsetting refinancing pressures.
What did this article say?
American Healthcare REIT (AHR) is highlighted as a low‑volatility, high‑quality defensive play in a market where rate uncertainty is rising. The article positions AHR alongside other stable assets, noting its income‑focused portfolio of clinical healthcare real estate. No recent earnings, guidance, or structural changes are disclosed, so the narrative remains a general positioning piece rather than a catalyst. Investors may view AHR as a ballast in a volatile environment, but the piece offers no new data that would materially shift expectations. The focus is on AHR’s role in a defensive strategy rather than on any specific financial event.
What did this article say?
American Healthcare REIT (AHR) announced a $0.25 per share cash distribution for the quarter ending September 30, 2026, payable on October 16, 2026. The declaration comes from the board of directors and reflects the company’s ongoing dividend policy. The payout is a routine event and does not signal any change in earnings guidance or operational outlook.

Technical Analysis

Real-time indicators across multiple timeframes

14
BEARISH
Technical indicators reflect the latest computed signal mix for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
1 tracked managers · $112.03M combined position · 0 adding, 0 trimming, 1 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Citadel Advisors LLC• Hold2,148,3140.98%$112.03M2026-09-02
Q2 2026 flow:2.15M sh bought ($112.03M)0 sh sold ($0)net +2.15M sh (+$112.03M)